ChemicalBook > CAS DataBase List > Bevirimat

Bevirimat

Product Name
Bevirimat
CAS No.
174022-42-5
Chemical Name
Bevirimat
Synonyms
BVM;PA-457;CS-1322;FH 11327;MPC-4326;Bevirimat;Bevirimat, >99%;Bevirimat(PA-457);BVM; MPC-4326; PA-457;Bevirimat 174022-42-5
CBNumber
CB22498801
Molecular Formula
C36H56O6
Formula Weight
584.83
MOL File
174022-42-5.mol
More
Less

Bevirimat Property

Melting point:
>263°C (dec.)
Boiling point:
662.7±40.0 °C(Predicted)
Density 
1.13±0.1 g/cm3(Predicted)
storage temp. 
Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility 
Acetonitrile (Slightly), Methanol (Very Slightly, Heated, Sonicated)
form 
Solid
pka
4.48±0.28(Predicted)
color 
White to Off-White
Stability:
Hygroscopic
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML2057
Product name
Bevirimat
Purity
≥98% (HPLC)
Packaging
5 mg
Price
$135
Updated
2025/07/31
Sigma-Aldrich
Product number
SML2057
Product name
Bevirimat
Purity
≥98% (HPLC)
Packaging
25 mg
Price
$545
Updated
2025/07/31
Cayman Chemical
Product number
21339
Product name
PA-457
Purity
≥98%
Packaging
1mg
Price
$62
Updated
2024/03/01
Cayman Chemical
Product number
21339
Product name
PA-457
Purity
≥98%
Packaging
5mg
Price
$254
Updated
2024/03/01
Cayman Chemical
Product number
21339
Product name
PA-457
Purity
≥98%
Packaging
10mg
Price
$477
Updated
2024/03/01
More
Less

Bevirimat Chemical Properties,Usage,Production

Description

PA-457 is an inhibitor of HIV-1 virion maturation. It inhibits the cleavage of the Gag capsid (CA) precursor CA-SP1 to the mature CA protein. PA-457 inhibits the replication of drug-sensitive and -resistant clinical isolates of HIV-1 in isolated human peripheral blood mononuclear cells (PBMCs; mean IC50s = 10.3 and 7.8 nM, respectively). In vivo, it prevents replication of HIV-1 in SCID-hu Thy/Liv mice when administered at a dose of 100 mg/kg.

Chemical Properties

White crystalline powder, soluble in methanol, ethanol, DMSO and other organic solvents.

Uses

Bevirimat is a HIV-1 maturation inhibitor, targetting the Gag CA-SP1 cleavage site. HIV Inhibitor.

Definition

ChEBI: A pentacyclic triterpenoid obtained by the formal condensation of 2,2-dimethylsuccinic acid with the 3-hydroxy group of betulinic acid. It is isolated from the Chinese herb Syzygium claviflorum. The first in the class of HIV-1 maturation inhib tors to be studied in humans, bevirimat was identified as a potent HIV drug candidate and several clinical trials were conducted, but development into a new drug was plagued by numerous resistance-related problems.

Enzyme inhibitor

This first-in-class, natural product-based antiviral (FW = 584.83 g/mol; CAS 174022-42-5; Abbreviation: BVM), also known as 3-O-(3',3'- dimethylsuccinyl)betulinate (DSB), 3β-(3-carboxy-3-methyl-butanoyloxy)- lup-20(29)-en-28-oic acid, PA-457, and MPC-4326, is a novel HIV-1 maturation inhibitor that blocks proteolytic processing of the Gag capsid precursor (CA-SP1) into mature capsid (CA) protein. Bevirimat binds to the Gag polypeptide at the CA/SP1 cleavage site. The net result of BVM treatment is the release of immature, noninfectious viral particles. Despite its promising mode of action, about half of all patients have viruses containing genetic polymorphisms in the Gag SP1 (at positions 6 to 8) protein do not respond to BVM treatment.

target

HIV

References

[1] DAVID E MARTIN  Graham P A  Karl Salzwedel. Bevirimat: a novel maturation inhibitor for the treatment of HIV-1 infection.[J]. Antiviral Chemistry and Chemotherapy, 2008, 19 3: 107-113. DOI: 10.1177/095632020801900301
[2] DAN WANG  Feng L  Wuxun Lu. Pharmacological intervention of HIV-1 maturation[J]. Acta Pharmaceutica Sinica. B, 2015, 5 6: Pages 493-499. DOI: 10.1016/j.apsb.2015.05.004
[3] F LI. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2003, 100 23: 13555-13560. DOI: 10.1073/pnas.2234683100
[4] CHERYL A STODDART. Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice.[J]. PLoS ONE, 2007: e1251. DOI: 10.1371/journal.pone.0001251

Bevirimat Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Bevirimat Suppliers

Pharma Affiliates
Tel
--
Fax
--
Email
@pharmaffiliates.com
Country
India
ProdList
6754
Advantage
58
SynZeal Research Pvt Ltd
Tel
--
Fax
--
Email
standards@synzeal.com
Country
India
ProdList
6514
Advantage
58
Pharmaffiliates Analytics and Synthetics P. Ltd
Tel
--
Fax
--
Email
mktg@pharmaffiliates.com
Country
India
ProdList
6739
Advantage
58
More
Less

View Lastest Price from Bevirimat manufacturers

Hebei Chuanghai Biotechnology Co., Ltd
Product
Bevirimat 174022-42-5
Price
US $8.89/KG
Min. Order
1KG
Purity
99%
Supply Ability
10 mt
Release date
2024-11-22
NanJing Spring & Autumn Biological Engineering CO., LTD.
Product
Bevirimat 174022-42-5 174022-42-5
Price
US $62.00/mg
Min. Order
20mg
Purity
≥98%
Supply Ability
1000.00 kgs
Release date
2019-07-09
Career Henan Chemical Co
Product
Bevirimat 174022-42-5
Price
US $9.80/KG
Min. Order
1KG
Purity
≥98%
Supply Ability
20 tons
Release date
2020-01-09

174022-42-5, BevirimatRelated Search:


  • Bevirimat 174022-42-5
  • Bevirimat, PA 457, FH 312
  • CS-1322
  • MPC-4326
  • PA-457; MPC-4326; FH11327; YK FH312
  • Bevirimat, >99%
  • BVM
  • BVM; MPC-4326; PA-457
  • Bevirimat
  • PA-457
  • FH 11327
  • O-(3,3-Dimethylsuccinyl)betulinic acid
  • Bevirimat(PA-457)
  • Lup-20(29)-en-28-oic acid, 3-(3-carboxy-3-methyl-1-oxobutoxy)-, (3β)-
  • (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-((3-Carboxy-3-methylbutanoyl)oxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-3aH-cyclopenta[a]chrysene-3a-carboxylic acid
  • Bevirimat, 10 mM in DMSO
  • 174022-42-5